Alnylam Hits Pfizer, Moderna With Patent Infringement Suits - Alnylam Pharmaceuticals (NASDAQ:ALNY), Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE)

Alnylam Pharmaceuticals Inc ALNY has filed separate lawsuits in the Delaware federal court against Pfizer Inc PFE and Moderna Inc MRNA, seeking damages for infringement of a patent in the manufacture and sale of their mRNA COVID-19 vaccines.
Alnylam said it was seeking compensation for the use of its lipid nanoparticles (LNP) technology that carries and delivers RNA-based therapeutics or vaccines in the body.
The pharmaceutical firm said that Pfizer and Moderna's vaccines infringe Alnylam's patent by using a lipid formulated into LNPs that protect and deliver the vaccines' mRNA.
Read Next: Arbutus Hits Moderna With New Suit Claiming COVID-19 Vaccine Patent(s).
Alnylam said it does not intend to take action that impedes the vaccines' production, sale, or distribution.
Price Action: PFE stock is up 2.15% at $54.06 during the market session on the last check Thursday.